RecruitingNCT06970288
Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection
Sponsor
Ain Shams University
Enrollment
85 participants
Start Date
May 10, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is to evaluate the added value of non-contrast abbreviated MRI protocol featuring ultra-high B value Diffusion Weighted Imaging to detect, characterize suspicious breast lesions and avoid using contrast.
Eligibility
Sex: FEMALEMin Age: 30 YearsMax Age: 50 Years
Plain Language Summary
Simplified for easier understanding
This study is testing whether a modified, shorter breast MRI scan that uses ultra-high strength imaging (without the usual contrast dye) can detect breast cancer just as well as standard MRI — making screening faster and more accessible for women at high risk.
**You may be eligible if...**
- You are a woman with a suspicious breast lump (rated BIRADS 4a on imaging)
- You have a significant family history of breast cancer
- You have suspicious lymph nodes under your arm detected by ultrasound
- You have dense breast tissue and are referred for an MRI
**You may NOT be eligible if...**
- You have a pacemaker, cochlear implant, certain eye implants, or severe claustrophobia that prevent MRI
- You have kidney problems that prevent contrast material use (though this study avoids contrast, so mainly applies to standard exclusions)
- You have not yet had a recent mammogram and ultrasound
- You have already had a biopsy or breast intervention recently
- You declined participation
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06970288
Related Trials
Mobile Health for Adherence in Breast Cancer Patients
NCT06112613400 locations
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
NCT0618475011 locations
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589837 locations
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
NCT054062321 location
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NCT070671381 location